Evicenter
MarkdownMedical informationP&T meetings
Deucrictibant (PHA121)

On-demand treatment of hereditary angioedema attacks

Also known as PHA-022121
Manufacturer
Pharvaris
Last updated
209 sources

Product information and disease descriptionProduct descriptionProduct informationPharmacology

Pharmacokinetics

13 evidence topics · 11 sources

Single ascending doses of oral solution in healthy volunteers: pharmacokinetic parameters
Parameter1 mg fasted2 mg fasted4.5 mg fasted12 mg fasted22 mg fasted22 mg after high-calorie, high-fat breakfast
Cmax, ng/mL, mean (SD)“11.1 (4.03)”“19.8 (3.70)”“32.9 (7.66)”“97.3 (28.1)”“213 (49.5)”“145 (56.2)”
AUClast, ng.h/mL, mean (SD)“33.0 (25.9)”“66.0 (27.0)”“129 (56.5)”“369 (194)”“681 (113)”“1015 (490)”
t1/2, h, mean (SD)“3.49 (1.32)”“4.26 (1.91)”“4.36 (1.29)”“4.25 (0.831)”“5.61 (0.707)”“5.31 (1.54)”
CL/F, L/h, mean (SD)“42.3 (25.4)”“33.8 (11.9)”“37.6 (11.1)”“40.9 (20.7)”“31.5 (5.60)”“25.3 (9.77)”